BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kinoshita S, Hirai R, Yamano T, Yuasa I, Tsukuda K, Shimizu N. Angiogenesis inhibitor TNP-470 can suppress hepatocellular carcinoma growth without retarding liver regeneration after partial hepatectomy. Surg Today. 2004;34:40-46. [PMID: 14714227 DOI: 10.1007/s00595-003-2645-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Semela D, Dufour JF. Angiogenesis and hepatocellular carcinoma. J Hepatol. 2004;41:864-880. [PMID: 15519663 DOI: 10.1016/j.jhep.2004.09.006] [Cited by in Crossref: 250] [Cited by in F6Publishing: 236] [Article Influence: 14.7] [Reference Citation Analysis]
2 Shi JH, Line PD. Effect of liver regeneration on malignant hepatic tumors. World J Gastroenterol 2014; 20(43): 16167-16177 [PMID: 25473170 DOI: 10.3748/wjg.v20.i43.16167] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
3 Li J, Tan H, Dong X, Xu Z, Shi C, Han X, Jiang H, Krissansen G, Sun X. Antisense integrin αV and β3 gene therapy suppresses subcutaneously implanted hepatocellular carcinomas. Digestive and Liver Disease 2007;39:557-65. [DOI: 10.1016/j.dld.2007.01.025] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
4 Li L, Yuan YZ, Lu J, Xia L, Zhu Y, Zhang YP, Qiao MM. Treatment of pancreatic carcinoma by adenoviral mediated gene transfer of vasostatin in mice. Gut 2006;55:259-65. [PMID: 16287901 DOI: 10.1136/gut.2005.064980] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
5 Ma L, Luo L, Qiao H, Dong X, Pan S, Jiang H, Krissansen GW, Sun X. Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapy. Journal of Hepatology 2007;46:98-106. [DOI: 10.1016/j.jhep.2006.07.031] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
6 Chen JA, Shi M, Li JQ, Qian CN. Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration. Hepatol Int 2010;4:537-47. [PMID: 21063476 DOI: 10.1007/s12072-010-9192-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
7 Vidal-vanaclocha F. The Tumor Microenvironment at Different Stages of Hepatic Metastasis. In: Brodt P, editor. Liver Metastasis: Biology and Clinical Management. Dordrecht: Springer Netherlands; 2011. pp. 43-87. [DOI: 10.1007/978-94-007-0292-9_3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Olaso E, Arteta B, Salado C, Eguilegor E, Gallot N, Lopategi A, Gutierrez V, Solaun M, Mendoza L, Vidal-vanaclocha F. Proangiogenic Implications of Hepatic Stellate Cell Transdifferentiation into Myofibroblasts Induced by Tumor Microenvironment. Tissue Repair, Contraction and the Myofibroblast. Boston: Springer US; 2006. pp. 88-101. [DOI: 10.1007/0-387-33650-8_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Peng XC, Wang M, Chen XX, Liu J, Xiao GH, Liao HL. Plasmid-encoding vasostatin inhibited the growth and metastasis of human hepatocellular carcinoma cells. Mol Cell Biochem 2014;395:265-72. [PMID: 24997628 DOI: 10.1007/s11010-014-2135-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
10 Lah JJ, Cui W, Hu KQ. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 2007; 13(40): 5299-5305 [PMID: 17879397 DOI: 10.3748/wjg.v13.i40.5299] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
11 Tse LY, Sun X, Jiang H, Dong X, Fung PW, Farzaneh F, Xu R. Adeno-associated virus-mediated expression of kallistatin suppresses local and remote hepatocellular carcinomas. J Gene Med. 2008;10:508-517. [PMID: 18338836 DOI: 10.1002/jgm.1180] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
12 Jiang X, Li H, Qiao H, Jiang H, Xu R, Sun X. Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice. Cancer Sci 2009;100:2226-33. [PMID: 19709125 DOI: 10.1111/j.1349-7006.2009.01306.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
13 Shi JH, Huitfeldt HS, Suo ZH, Line PD. Growth of hepatocellular carcinoma in the regenerating liver. Liver Transpl. 2011;17:866-874. [PMID: 21542129 DOI: 10.1002/lt.22325] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]